Ad is loading...
MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2024 All rights reserved. Tickeron Inc.
LCTX
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION

Lineage Cell Therapeutics (LCTX) Earnings Date & Reports

A.I. Advisor
published Earnings

LCTX is expected to report earnings to rise 83.50% to -3 cents per share on March 06

Lineage Cell Therapeutics LCTX Stock Earnings Reports
Q4'24
Est.
$-0.04
Q3'24
Beat
by $0.02
Q2'24
Beat
by $0.02
Q1'24
Est.
$-0.04
Q4'23
Beat
by $0.01
The last earnings report on November 14 showed earnings per share of -1 cents, beating the estimate of -3 cents. With 15.61M shares outstanding, the current market capitalization sits at 115.05M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
LCTX
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View Trends For LCTX
(Try 14 days for Free)
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, and neurological conditions

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2173 Salk Avenue
Phone
+1 442 287-8990
Employees
75
Web
https://www.lineagecell.com